OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...

Altman and Musk were OpenAI’s founding co-chairs in 2015, but their relationship has devolved into name-calling and lawsuits.

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...

Elon Musk is clashing with OpenAI CEO Sam Altman over the Stargate artificial intelligence infrastructure project touted by ...

Tensions between technology leaders Elon Musk and OpenAI CEO Sam Altman were on full display this week after the Tesla CEO ...

Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in ...

The US will be able to achieve AGI, or artificial general intelligence, with President Donald Trump's new Stargate AI project, OpenAI CEO Sam Altman said on Tuesday. Altman was at the White House ...

OpenAI, led by CEO Sam Altman, is backing an initiative known as AI 2030, which is aimed at shaping "public dialogue about U.S. competition against China on AI," Politico reported in October.

Impact Link Over the years, OpenAI CEO Sam Altman has shared predictions about where he thinks we're headed on artificial general intelligence, superintelligence, agentic AI, and more — and when ...

OpenAI CEO Sam Altman is set to hold a private briefing ... Sources suggest OpenAI is nearing the release of “super-agents”—AI systems capable of performing complex, Ph.D.-level tasks ...

Sam Altman has shut down online "hype" after rumors ... Rumors that the company had achieved AGI, defined as a type of AI capable of understanding, learning, and performing any intellectual ...

Sam Altman, the CEO of OpenAI, now says he is more confident of a fast AI takeoff. A fast AI takeoff is more possible than he thought a couple of years ago. He suggested this could happen within a ...